New Study to Get More Minorities Involved in Genetic Testing
Dr. Nicolette Rodriguez leads the REGENERATE study to find the best ways to get more Black and Latinx Americans genetic testing for cancer.
Learning to Recognize the Symptoms of Pancreatic Cancer
Laura Metzger had many different symptoms of pancreatitis and pancreatic cancer but no one put the picture together for years.
Evaluating Different Immunotherapy Combinations
A platform clinical trial evaluates immunotherapy combinations with standard of care treatment for advanced pancreatic cancer.
Claudin May Be the Next Big Target in Pancreatic Cancer Treatment
While immunotherapy and other targeted treatments involving monoclonal antibodies have been successful in other cancers, pancreatic cancer has been notoriously tough to target because of a lack of suitable cell surface targets to which the antibodies can bind. But a new target has been identified, and researchers are hopeful that an investigational drug that homes…
Vigilance Leads to Pancreatic Cancer Diagnosis
After his pancreatic cancer diagnosis, Michael Whalen searched for someone willing to treat him with chemotherapy.
Learn More About Qualifying for Clinical Trials
Dr. Anup Kasi provides in-depth information and answers questions about qualifying for pancreatic cancer clinical trials.
Two New Immunotherapy Trials Aim to Make Therapy More Effective
Two clinical trials in the Lustgarten Foundation’s Clinical Accelerator are testing different combinations of immunotherapy.
An Update on Vitamin C and Cancer
Dr. Lewis Cantley discusses the latest research on and clinical trials of vitamin C for KRAS-mutated and pancreatic cancer.
Testing a Combination for Metastatic Pancreatic Cancer
A clinical trial tests an investigational drug, immunotherapy, and radiation in combination against advanced pancreatic cancer.
Large Phase III Global Trial Targets Cancer Metabolism
Dr. Philip Philip focuses on disrupting cancer cell metabolism with devimistat, now in a phase III global clinical trial.